1. Pharmacological inhibition of catalase induces peroxisome leakage and suppression of LPS induced inflammatory response in Raw 264.7 cell.
- Author
-
Mu Y, Maharjan Y, Kumar Dutta R, Wei X, Kim JH, Son J, Park C, and Park R
- Subjects
- Animals, Cytokines genetics, Gene Expression Regulation drug effects, Inflammation chemically induced, Inflammation metabolism, Mice, NF-kappa B metabolism, Proteasome Endopeptidase Complex metabolism, Proteolysis drug effects, RAW 264.7 Cells, RNA, Messenger genetics, Reactive Oxygen Species metabolism, Catalase antagonists & inhibitors, Enzyme Inhibitors pharmacology, Lipopolysaccharides pharmacology, Peroxisomes drug effects, Peroxisomes metabolism
- Abstract
Peroxisomes are metabolically active organelles which are known to exert anti-inflammatory effects especially associated with the synthesis of mediators of inflammation resolution. However, the role of catalase and effects of peroxisome derived reactive oxygen species (ROS) caused by lipid peroxidation through 4-hydroxy-2-nonenal (4-HNE) on lipopolysaccharide (LPS) mediated inflammatory pathway are largely unknown. Here, we show that inhibition of catalase by 3-aminotriazole (3-AT) results in the generation of peroxisomal ROS, which contribute to leaky peroxisomes in RAW264.7 cells. Leaky peroxisomes cause the release of matrix proteins to the cytosol, which are degraded by ubiquitin proteasome system. Furthermore, 3-AT promotes the formation of 4HNE-IκBα adduct which directly interferes with LPS induced NF-κB activation. Even though, a selective degradation of peroxisome matrix proteins and formation of 4HNE- IκBα adduct are not directly related with each other, both of them are could be the consequences of lipid peroxidation occurring at the peroxisome membrane., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF